Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, A. J.
Right arrow Articles by Littenberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. J.
Right arrow Articles by Littenberg, B.
(Radiology. 2001;218:791-797.)
© RSNA, 2001


Neuroradiology

Evaluation of a Reduced MR Imaging Sequencing Protocol in Adult Patients with Stroke1

Annette J. Johnson, MD, Daniel K. Kido, MD, William D. Shannon, PhD, Mark M. Bahn, MD, PhD, Mokhtar H. Gado, MD, Benjamin C. P. Lee, MD, Christopher J. Moran, MD, Franz J. Wippold, II, MD and Benjamin Littenberg, MD

1 From the Mallinckrodt Institute of Radiology (A.J.J., D.K.K., M.M.B., M.H.G., B.C.P.L., C.J.M., F.J.W.), Department of Medicine (A.J.J., W.D.S., B.L.), and Division of Biostatistics (W.D.S.), Washington University School of Medicine, St Louis, Mo; the Department of Medicine, University of Vermont College of Medicine, Burlington (B.L.); and the Department of Radiology, University of Alabama at Birmingham (A.J.J.). Received April 12, 2000; revision requested June 5; revision received July 28; accepted August 29. Address correspondence to A.J.J., Indiana University Radiology Research Institute 714 N Senate Ave, 1st Floor, Indianapolis, IN 46202 (e-mail: annejohn@iupui.edu).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 
PURPOSE: To compare a reduced (three-sequence) magnetic resonance (MR) imaging protocol with a full (eight- to 10-sequence) MR imaging protocol in adults suspected of having stroke.

MATERIALS AND METHODS: Six neuroradiologists interpreted a consecutive sample of 265 MR images in patients suspected of having stroke. Each read reduced-protocol images in a discrete series of 40 patients (one read images in only 15) and corresponding full-protocol images 1 month later (reduced/full protocol). Five of the readers each read images in 10 additional cases, five each as full/full and reduced/reduced protocol controls. {kappa} values between full and reduced protocols, reader assessment of protocol adequacy, confidence level, and need for additional sequences or examinations were evaluated.

RESULTS: In the reduced/full protocol, the {kappa} value for detecting ischemia was 0.797; and that for detecting any clinically important abnormality, 0.635. Statistically similar {kappa} values were found with the full/full control design ({kappa} = 0.802 and 0.715, respectively). The full protocol was judged more adequate than the reduced protocol (2.0 of 5.0 points vs 1.6, P < .001) and generated greater diagnostic confidence (8.6 of 10.0 points vs 8.9, P = .01), less need for additional sequences (2.7 of 6.0 points vs 1.5, P < .001), and more requests for additional examinations (28.4% vs 36.3%).

CONCLUSION: Disagreement between interpretations of reduced- and full-protocol images might be attributable to baseline-level intraobserver inconsistency, as demonstrated in control designs. A greater number of sequences did not lead to greater consistency.

Index terms: Brain, ischemia, 10.78 • Brain, MR, 10.121413, 10.121419


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 
Stroke affects 500,000 individuals annually and is the third leading cause of death in the United States (1), with an estimated annual cost of approximately $30 billion (2). Part of this large sum pays for diagnostic evaluation, which includes neuroimaging. Approximately 42% of adult patients with stroke who are treated by a hospital neurology service undergo magnetic resonance (MR) imaging of the brain (3). A designated set of sequences performed in a particular clinical setting, such as adult stroke, form an MR imaging protocol. MR imaging protocols for stroke vary widely among institutions and sometimes within a radiology section, with no broadly accepted standard. New MR imaging sequences are constantly being developed, contributing to this variation.

In late 1997, 26 MR imaging sequences for brain imaging were available at the Mallinckrodt Institute of Radiology. We performed eight to 10 of these sequences in our protocol (full protocol) for adults suspected of having stroke. Theoretic justification and anecdotal experience dictated which sequences were retained in the stroke protocol over the years. In general, the greater the number of sequences, the greater the imaging time per patient, film usage, and cost and, potentially, the fewer the number of patients undergoing imaging per day. Decreasing the number of sequences in a protocol, especially one as commonly used as that in adult stroke, could potentially decrease costs and patient backlog and increase patient satisfaction (due to decreased scheduling delays and imaging time) and the cost-effectiveness of this diagnostic examination. Routine use of intravenously administered MR imaging contrast agents in our full protocol is also associated with increased cost and some, albeit minimal, risk to the patient because of idiosyncratic or allergic-type reactions.

The purpose of our study was to compare the performance of a reduced (three-sequence) MR imaging protocol with that of a full (eight- to 10-sequence) MR imaging protocol in adults suspected of having stroke. We are ultimately interested in improving our function as diagnosticians. The validity of a diagnostic examination, such as MR imaging, essentially has three components: reliability (or consistency, defined as the capacity of a test to give the same result at repeated application), responsiveness, and discrimination. The latter two were beyond the scope of the current study. In particular, we did not examine the validity of our reduced protocol in discriminating between patient populations. Instead, we focused on reliability—in particular, intraobserver reliability. We suspect that a greater amount of information (ie, the number of images and/or sequences) leads to some improvement in the reliability of interpretations by the same observer. In this study, we compared intraobserver reliability for detecting ischemia and other important abnormalities by using reduced versus full protocols and compared diagnostic confidence level, need for additional sequences, recommendations for additional diagnostic examinations, and adequacy of the examination for diagnosis by using reduced versus full protocols.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 
Development of the Reduced Protocol
The study was approved by the Mallinckrodt Institute of Radiology’s Institutional Human Studies Committee, which determined that informed consent was not necessary. In a pilot study, seven neuroradiologists (including D.K.K., B.C.P.L., M.M.B., F.J.W., and M.H.G.) were each systematically shown images from three MR imaging stroke cases. Initially, each reader was shown only transverse T1-weighted spin-echo and T2-weighted turbo spin-echo images and asked to indicate the most likely diagnosis and his or her confidence in this diagnosis on a scale of one (low confidence) to 10 (high confidence). The reader was asked whether he or she was comfortable enough with the diagnosis to stop at this point or wanted to request review of another sequence. Any requested sequences were performed, and these steps were repeated until the reader was comfortable stopping or all available images from the sequences had been viewed. Finally, the reader was shown the entire full protocol and asked what difference (ie, change in diagnosis or confidence level) the additional sequences made. Our pilot data showed that the neuroradiologists were comfortable with their diagnoses after viewing images from three to five sequences (mean number of sequences, 3.5).

After reviewing the results of this pilot study, five neuroradiology staff members (D.K.K., B.C.P.L., M.M.B., F.J.W., and M.H.G.) chose by means of consensus a reduced protocol of three sequences for the setting of stroke of uncertain age (Figure). (At our institution, the duration of symptoms was typically not known to the technologist or neuroradiologist at the time of imaging.) This reduced protocol is consistent with current literature concerning useful sequences in patients with stroke (48), although the exact content of such an ideal protocol will vary over time as newer sequences are developed. This group expressed an interest in adding a fourth "blood-sensitive" sequence such as echo-planar T2*-weighted imaging to the reduced protocol. However, at that time, this sequence was not in routine use at our institution in adult patients with stroke, since we still performed nonenhanced cranial computed tomography (CT) to exclude acute hemorrhage in essentially all patients with stroke; therefore, T2*-weighted imaging was not included in our reduced protocol.



View larger version (52K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. List shows the MR imaging sequences included in the full and reduced stroke protocols. DWI = diffusion-weighted imaging, FLAIR = fluid-attenuated inversion recovery.

 
Evaluation of Reduced Protocol
The study cases were a consecutive sample of previously performed full-protocol MR imaging examinations in patients with stroke. All imaging was performed by using one of three imagers: Vision 1.5 T, Impact 1.0 T (Siemens, Erlangen, Germany), or Signa Horizon 1.5 T (GE Medical Systems, Milwaukee, Wis). Cases were identified retrospectively by searching ICD9 codes related to stroke (for cerebrovascular accident, cerebrovascular disease or lesion, cerebral embolism, cerebellar infarction, transient intermittent ischemia, cerebral thrombosis, cerebrovascular disease, and late effect cerebrovascular accident) for cranial MR imaging examinations performed between January 1997 and September 1997; thus, strokes of varying ages were probably included. Inclusion criteria were identification with this ICD9 code search (cases could have been coded according to history and/or MR imaging findings) and a patient age of at least 16 years. The authors acknowledge that using ICD9 coding in this manner may have biased sampling to include more patients with MR imaging findings that were consistent with stroke. However, it was not practical to determine precisely why coders chose particular codes; therefore, this convenience sample was chosen. Exclusion criteria were failure of the examination to include all components of the reduced protocol and repeat imaging in an included patient.

Six neuroradiologists on the medical staff at our institution (D.K.K., M.M.B., M.H.G., B.C.P.L., C.J.M., and F.J.W.) participated in the study as readers who ranged in age from 43 to 66 (mean age, 53) years and in years of neuroradiologic experience from 4 to 30 (mean number of years of experience, 19).

Each reader was assigned a different set of 50 patients so that no two readers read the same patient’s images. Each set of 50 patients’ images was divided into three subsets: 40 patients in the primary study design, five in the secondary study design, and five in the tertiary study design. In the primary study design (reduced/full), each reader read a subset of 40 images from his series, first as a randomly ordered set of the sequences that formed the reduced protocol, and then 1 month later in the same patients as images from the set of sequences that formed the full protocol. The secondary design (reduced/reduced protocol control) consisted of each reader being shown first the reduced protocol images in five patients, and then, 1 month later, the identical reduced protocol images in these same five patients. The tertiary design (full/full protocol control) consisted of each reader being shown first the full-protocol images in five patients, and then, 1 month later, the identical full-protocol images in these same five patients.

The same reader interview (Appendix) was used for all study designs. The interviewer supplied patient age, sex, and history from the requisition for the image. With each reading, the reader was required to offer a diagnosis and a confidence level in that diagnosis on a scale from one (low) to 10 (high). Readers also were questioned regarding the overall adequacy of the images for diagnosis and the desire for additional MR imaging sequences or other diagnostic examinations. The interview was conducted by the first author, who used a standardized interview and data recording format.

Analysis
For detecting ischemia and other clinically important abnormalities, we calculated the percentage of agreement (the number of concordant readings divided by the total number of readings) and {kappa} values. When a finding is rare or common, the percentage of agreement tends to be high by chance alone. The {kappa} value is an adjustment of the percentage of agreement to accommodate chance agreement (9). It is calculated as (observed proportion of agreement - chance-expected proportion of agreement)/(1 - chance-expected proportion of agreement). {kappa} values range from -1.000 (perfect disagreement) to 1.000 (perfect agreement). Deciding quantitative levels for significance of {kappa} values is arbitrary, but the following guidelines for {kappa} values have been suggested: poor (<0), slight (0–0.200), fair (0.210–0.400), moderate (0.410–0.600), substantial (0.610–0.800), and excellent (0.810– 1.000) (9,10).

We performed the paired t test to compare means for diagnostic confidence level, rates of study adequacy, need for additional sequences, and recommendations for additional diagnostic studies. We also performed the Wilcoxon signed-rank test to evaluate the need for additional sequences, diagnostic confidence level, and rates of study adequacy. Results of these tests were reported as two-tailed analyses. To evaluate the effect of protocol on the rates of recommendation of additional diagnostic studies, we performed the McNemar {chi}2 test of the difference between rates in paired data (11). P values for differences in {kappa} values were calculated by performing the z test (9). STATA version 6 (Stata, College Station, Tex) was used for statistical analysis.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 
Two hundred sixty-five patients were included in the study. Five of the readers each read images in his assigned 50 patients (40 in the reduced/full protocol design, five in the reduced/reduced protocol control design, and five in the full/full protocol control design); one read images in only 15 of the assigned 50 patients (all in the reduced/full design) because of conflicting concurrent obligations. Basic demographic information on the study patients is presented in Table 1. In the 530 readings of these patients’ images (each patient’s images were read twice), only twice (0.4%) did the reader recognize the image from either previous clinical work or the previous study reading.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Study Patient Demographics
 
Reliability in Determining Ischemia
In the detection of ischemia, which was assessed by measures of agreement (raw agreement, {kappa}), the reduced protocol performed fairly well, as compared with the full protocol (Table 2). For comparison, this performance was similar to that of the second reading in the full/full protocol control group. The degree of consistency of the reduced/full protocol design in detecting ischemia ({kappa} = 0.797) was similar to that observed within the full/full protocol control design ({kappa} = 0.802). Likewise, the reduced/reduced protocol control had an intrinsic consistency ({kappa} = 0.816) that was similar to that of the full/full protocol control and to that of the reduced/full protocol. The three designs did not differ significantly in {kappa} value (P > .8). (See Tables 3 and 4 for specific findings that represented disagreements in the reduced/full protocol design with regard to ischemia and other clinically important abnormalities, respectively.) Calculated for individual readers, {kappa} values ranged from 0.610 to 0.900.


View this table:
[in this window]
[in a new window]

 
TABLE 2. Comparison of Reduced and Full Protocols for Detecting Ischemia
 

View this table:
[in this window]
[in a new window]

 
TABLE 3. Disagreements between Reduced and Full Protocols for Detecting Ischemia in 215 Patients
 

View this table:
[in this window]
[in a new window]

 
TABLE 4. Disagreements between Reduced and Full Protocols for Detecting Other Clinically Important Abnormalities in 215 Patients
 
For detecting hemorrhage (note that T2*-weighted imaging was not available for a majority of patients in our study), the {kappa} values were relatively poor for the reduced/full, full/full, and reduced/reduced protocol designs ({kappa} = 0.553, 0.457, and 0.242, respectively). The differences in these {kappa} values were not significant (P >= .40).

Reliability in Determining the Presence of Any Clinically Important Abnormality
Abnormalities considered clinically important included stroke, hemorrhage (excluding small chronic subdural hematomas), tumor or mass, meningeal disease, vasculitis, multiple sclerosis or other demyelinating disease, aneurysm, occlusion of a major artery, and hydrocephalus. Estimates of reliability were lower for determining the presence of any such abnormality than for detecting ischemia, with {kappa} values of less than 0.750 for the reduced/full, full/full, and reduced/reduced designs (Table 5). The small apparent differences in {kappa} values among the three designs were not significant (P > .6). Calculated for individual readers, {kappa} values ranged from 0.450 to 0.800.


View this table:
[in this window]
[in a new window]

 
TABLE 5. Comparison of Reduced and Full Protocols for Detecting Clinically Important Abnormalities
 
Diagnostic Confidence
Diagnostic confidence was significantly higher for the full protocol, as compared with the reduced protocol 1 month later (P = .007) (Table 6). However, the positive change observed (0.24 on a scale of one to 10) was nearly identical to that observed within the full/full protocol control over 1 month (0.22, P = .502).


View this table:
[in this window]
[in a new window]

 
TABLE 6. Comparison of Reduced and Full Protocols for Diagnostic Confidence
 
Rating of Clinical Adequacy
The full protocol was generally considered by readers to be more adequate than the reduced protocol by almost half a point for answering the clinical question of possible stroke (difference of 0.45, P < .001) on a five-point scale (Table 7). The full/full protocol control comparison also showed a significant (P = .026) improvement in adequacy rating of 0.28 on the five-point scale.


View this table:
[in this window]
[in a new window]

 
TABLE 7. Comparison of Reduced and Full Protocols for Adequacy
 
Need for Additional MR Imaging Sequences
Rates of requests for additional MR imaging sequences were significantly lower for the full protocol than for the reduced protocol (P < .001) (Table 8). The scores were stable over 1 month in the comparison with the full/full protocol control (P = .317), but not with the reduced/reduced protocol control (P = .039).


View this table:
[in this window]
[in a new window]

 
TABLE 8. Comparison of Reduced and Full Protocols for Requests for Additional MR Imaging Sequences
 
Recommendations for Additional Diagnostic Examinations
Sixty-one (28.4%) of 215 reduced-protocol interpretations led to recommendations for additional diagnostic examinations, as compared with 78 (36.3%) of 215 full-protocol interpretations. The McNemar {chi}2 test resulted in a P value of .01 for this difference being due to chance alone. The additional diagnostic examinations recommended included MR angiography, CT, conventional catheter angiography, Doppler ultrasonography of the carotid arteries, follow-up MR imaging, cerebrospinal fluid analysis, otolaryngologic consultation, and other miscellaneous examinations.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 
When compared with those based on our full protocol, our reduced-protocol interpretations agreed fairly well for detecting ischemia, but interpretations of the reduced protocol more often failed to agree with those of the full protocol for the presence of other clinically important abnormalities. However, the degree of disagreement we observed was of the same order of magnitude as that between repeat interpretations of the same images by the same reader 1 month later (ie, the full/full and reduced/reduced protocol controls for intraobserver reliability). The interpretation inconsistency between reduced and full protocols might be largely explained by the intrinsic baseline level of interpretation inconsistency seen with the full/full protocol design. Interpretations of the reduced/reduced protocol controls showed similar intrinsic inconsistency. It is not surprising that, without T2*-weighted imaging, all protocol designs showed relatively poor {kappa} values for diagnosing hemorrhage. In 1997, we continued to rely on nonenhanced cranial CT as the criterion standard for diagnosing acute intracranial hemorrhage (1217). In our study, we did not evaluate the utility of MR imaging for diagnosing hemorrhage.

Because the full protocol provides substantially more information than does the reduced protocol—about three times as many images—and because some of that information is redundant (ischemia is often visible with several sequences, for example), we expected the full protocol to provide additional opportunities for the reader to arrive at a consistent diagnosis. However, this did not happen. Regardless of the amount of information (reduced or full protocols), the interpretations were about equally reliable over 1 month.

The full protocol was more often considered adequate and generated greater confidence scores and fewer requests for additional MR imaging sequences than did the reduced protocol. As compared with the readers in the pilot studies performed to construct the reduced protocol, the readers in the primary study were more comfortable with the full protocol than with the reduced protocol.

It may be surprising that the full protocol generated significantly more requests for additional diagnostic testing. Determining the clinical utility of these requests was beyond the scope of this study—whether due to greater sensitivity (to additional true-positive abnormalities found by using additional diagnostic information) or to the higher false-positive rate of the full protocol. We are confident that the request for evaluation of the arterial system (with MR imaging, CT, or catheter angiography) would be considered appropriate in most patients with stroke.

Many extraneous sources of instability were eliminated by our research design. In the full/full and reduced/reduced control experiments, the same highly trained and experienced readers viewed exactly the same images of the same patients under similar conditions. The interval between interpretations for all three designs (4–6 weeks) was adequate to avoid reader recognition of patients at repeat reading.

Our study was limited by the relatively small set of readers from one institution. The formal interview may have increased reliability by systematically bringing the readers’ attention to the task of identifying ischemia, bleeding, and other abnormalities. Our ability to detect differences in pairs of {kappa} values was limited by our sample size. For ischemia (Table 2) and any clinically important abnormalities (Table 5), differences of about 0.3 would have been detectable, with a P value of less than .05. Thus, the small number of cases in the full/full and reduced/reduced control designs limited statistical power. Because of changes in the clinical protocols in use over time, the full protocol changed minimally from patient to patient over the duration of the study. All patients were chosen from a library of cases that occurred before the routine use of "blood-sensitive" sequences at our institution. It is possible that these sequences or another innovation would have a beneficial effect on reliability. Arguments could certainly be made for including different sequences in either the reduced or the full protocol. Also, sequences that are available at the date of publication of this study (including perfusion imaging) differ from those that were available at the time of our investigation. In our opinion, such new innovations merit additional investigation (eg, including tests of reliability and discrimination). Our study focused on recognizing areas for potential improvement in diagnostic function rather than on the latest evolving imaging technology.

We did not perform an accuracy study. We did not attempt to define a final reference diagnosis in each patient and do not know which interpretations best approximated the patients’ "true state." Similarly, without long-term follow-up, we were unable to distinguish which lesions resulted in substantial clinical dysfunction. Nonetheless, accuracy, in the sense of concordance with the findings of a reference examination, is not achievable if the index examination is unreliable. An examination that is unreliable cannot be accurate. We note that the reduced protocol is probably not appropriate for patients with a very gradual onset of symptoms, with symptom duration of longer than a few weeks, or with other manifestations suggesting a reasonable possibility of tumor or infection.

The degree of reliability of the interpretations in this study should be put into context. MR imaging has been widely embraced in the setting of stroke because of its superior diagnostic usefulness relative to alternative diagnostic examinations (4,1821). But are we using this technology to maximal benefit in this clinical setting? Some analysts describe {kappa} statistics in the 0.410–0.600 range as "moderate," in the 0.600–0.800 range as "substantial," and greater than 0.800 as "excellent" (9). However, if the clinical stakes are high, a {kappa} value of 0.800 may represent a level of performance that should perhaps be improved. Misinterpretation of ischemia 8%–10% of the time in patients with stroke ({kappa} = 0.800), as we observed, could mean that thousands of American adults are denied antiischemic agents. As an alternative, it could mean that thousands are inappropriately given these potentially dangerous agents (2224).

Why are readings not more reliable? Although we did not formally investigate this question, we offer several subjective observations. First, MR image interpretation is difficult and complex. It imposes a large cognitive burden on the reader and demands a high level of concentration. The amount of information resulting from even a single sequence is substantial and may be compounded in larger protocols. Second, readers must often perform without clues from the history (eg, duration of ischemic symptoms), physical examination, laboratory test results, or prior radiographs that would direct their attention to relevant aspects of the images. Third, readers sometimes approach images without a systematic strategy. Little in the environment or process of reporting helps to guide the reader. Images are rarely overread by a second radiologist. Fourth, training in radiology may emphasize differential diagnosis and maximum sensitivity rather than reliability. Neither trainees nor practicing radiologists are routinely informed of their own reliability. Finally, many radiologists and other physicians strive to perform at a high level, without recourse to routine aids such as checklists, guidelines, or standardized reporting criteria.

We wonder whether patients and clinicians expect or should reasonably expect readers to agree with themselves nearly 100% of the time under ideal testing circumstances. We know that even laboratory blood tests are not 100% reliable. However, the fact that 15%–20% of the time in our small control series, under nearly ideal conditions, the same readers gave inconsistent interpretations of major findings such as ischemia or other clinically important abnormalities warrants further investigation. Can similar consistency concerns be demonstrated in other modalities and clinical settings in medicine? Most important, what can be done to improve the reliability (and therefore the clinical utility) of imaging in patients with stroke? Reliability issues have been described in other diagnostic areas (25), but to our knowledge, no comprehensive strategy for addressing them is available. We propose that reliability is an improvable aspect of image interpretation and that changes in training, reporting format, equipment, environment, and physician behavior should be investigated to address this issue.

Our data suggest that in the clinical setting of suspected stroke, interpretations resulting from a reduced MR imaging protocol of three sequences disagreed about 15%–20% of the time with those resulting from a full protocol of eight to 10 sequences for detecting ischemia and other clinically important abnormalities; however, similar disagreement was seen among control interpretations. Readers were more comfortable with the full protocol. However, both protocols had intrinsic inconsistencies and unreliability that may have limited their accuracy and clinical usefulness. Before the diagnostic usefulness of any reduced protocol is further investigated (eg, by performing tests of accuracy and responsiveness to change), the reliability issues raised by less than optimally consistent interpretations in the controls must be investigated.


    APPENDIX
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 
Neuroradiologist interview:

Date of MR: ______Patient #_______________ History: ____YO_________________________

Please try not to look at the patient’s name while reviewing the scan. Please carefully review the images provided, and then answer the questions below based upon this scan.

1. What is your leading primary (that is, most important) diagnosis?
2. If your primary diagnosis is ischemia or CVA, please answer the questions below regarding your primary diagnosis:
(i) Is there evidence of CVA or ischemia?
 Yes 2  No
(ii) Is there evidence of hemorrhage?
 Yes  2  No  3  Not sure
(iii) What is the estimated age of the CVA?
 Hyperacute   Acute 3  Subacute 4  Chronic
(iv) What is the degree of mass effect?
 None 1  Mild  Moderate 3  Severe
(v) What is the size of the CVA?
 Small 2  Medium  Large
(vi) What is the primary vascular distribution of the CVA?
Side: 0  Right 1  Left 2  Bilateral
Vessel: 1  ACA 2  MCA 3  PCA  4  SCA 5  AICA 6  PICA  7  Other__________

3. How confident are you in this diagnosis now? (Please rate 1 to 10, with 1 being the least confident and 10 being the greatest.)  
4. How clinically significant do you think this diagnosis is? (Please rate 1 to 10, with 1 being lest confident and 10 being highly significant.)  
5. Please list any secondary diagnoses (excluding sinus disease) apparent from these images. After each diagnosis, please answer the following two questions:
(i) How confident are you in this diagnosis now? (Please rate from 1 to 10, with 1 being least confident and 10 being greatest.)
(ii) How clinically significant do you think this diagnosis is? (Please rate from 1 to 10, with 1 being least significant and 10 being highly significant.)
Secondary Diagnosis Confidence Significance
(b)_____________________           
(c)_____________________           
(d)_____________________           
(e)_____________________           
(f)______________________           
(g)_____________________           

6. The next question involves your options in obtaining additional MR sequences on this patient. Would you order additional MR sequences, considering the possible inconvenience to the patient and others?
1.  No—I’m comfortable reading the scan as is.
2.  No—even though I’m uncomfortable, I would not call the patient back.
3.  Yes—but only if the patient was still in the scanner.
4.  Yes—but only if the patient was still in the MR suite.
5.  Yes—but only if the patient was still in the hospital.
6.  Yes—even if the patient has left the hospital.

7. "Overall, this scan was adequate for the clinical question."
Regarding the above statement, mark an "X" on the line that best represents your opinion:
       Strongly    Neutral    Disagree
       agree                  Strongly;
Agree   (1)   (2)   (3)   (4)  disagree (5)
           ___   ___   ___   ___   ___

8. Would you recommend any non-MR or specialized MR imaging for this patient?
 Yes  2  No
If yes, what do you recommend?
__________________
9. Do you recognize this case?
 Yes  0  No

Thank you for completing this questionnaire.

Date: _____________ NR: _____________


    FOOTNOTES
 
Author contributions: Guarantors of integrity of entire study, A.J.J., B.L.; study concepts and design, all authors; definition of intellectual content, all authors; literature research, A.J.J., D.K.K.; clinical studies, all authors; data acquisition, A.J.J., D.K.K., M.M.B., M.H.G., B.C.P.L., C.J.M., F.J.W.; data analysis, A.J.J., D.K.K., B.L.; statistical analysis, A.J.J., W.D.S., B.L.; manuscript preparation, A.J.J., B.L.; manuscript editing and review, all authors.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 APPENDIX
 REFERENCES
 

  1. American Heart Association. 1995 heart and stroke facts and statistics Dallas, Tex: American Heart Association, 1994.
  2. National Stroke Association. Cost of stroke. Stroke Clin Updates 1994; 5:9-12.
  3. Alberts MJ, Bennett CA, Rutledge VR. Hospital charges for stroke patients. Stroke 1996; 27:1825-1828.[Abstract/Free Full Text]
  4. Yuh WTC, Crain MR, Loes DJ, Greene GM, Ryals TJ, Sato Y. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR Am J Neuroradiol 1991; 12:621-629.[Abstract]
  5. Tong DC, Yenari MA, Albers GW, O’Brien M, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998; 50:864- 870.[Abstract/Free Full Text]
  6. Ebisu T, Tanaka C, Umeda M, et al. Hemorrhagic and nonhemorrhagic stroke: diagnosis with diffusion-weighted and T2-weighted echo-planar MR imaging. Radiology 1997; 203:823-828.[Abstract/Free Full Text]
  7. van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998; 29:1783-1790.[Abstract/Free Full Text]
  8. Alexander JA, Sheppard S, Davis PC, Salverda P. Adult cerebrovascular disease: role of modified rapid fluid-attenuated inversion-recovery sequences. AJNR Am J Neuroradiol 1996; 17:1507-1513.[Abstract]
  9. Kramer MS, Feinstein AR. Clinical biostatistics LIV. The biostatistics of concordance. Clin Pharmacol Ther 1981; 29:111-123.[Medline]
  10. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.[Medline]
  11. Fleiss J. The analysis of data from matched samples. In: Fleiss J, eds. Statistical methods for rates and proportions. 2nd ed. New York, NY: Wiley, 1981; 112-137.
  12. Silverboard G, Horder MH, Ahmann PA, Lazzara A, Schwartz JF. Reliability of ultrasound in diagnosis of intracerebral hemorrhage and posthemorrhagic hydrocephalus: comparison with computed tomography. Pediatrics 1980; 66:507-514.[Abstract/Free Full Text]
  13. Silverboard G, Lazzara A, Ahmann PA, Schwartz JF. Comparison of lumbar puncture with computed tomography scan as an indicator of intracerebral hemorrhage in the preterm infant. Pediatrics 1980; 66:432-437.[Abstract/Free Full Text]
  14. Zimmerman RD, Heier LA, Snow RB, Liu DPC, Kelly AB, Deck MDF. Acute intracranial hemorrhage: intensity changes on sequential MR scans at .5 T. AJR Am J Roentgenol 1988; 150:651-661.[Abstract/Free Full Text]
  15. Bradley WG. MR appearance of hemorrhage in the brain. Radiology 1993; 189:15-26.[Abstract/Free Full Text]
  16. Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 1996; 27:2321- 2324.[Abstract/Free Full Text]
  17. Di Chiro G, Brooks RA, Girton ME, et al. Sequential MR studies of intracerebral hematomas in monkeys. AJNR Am J Neuroradiol 1986; 7:193-199.[Abstract]
  18. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997; 42:164-170.[Medline]
  19. Bryan RN, Levy LM, Whitlow WD, Killian JM, Preziosi TJ, Rosario JA. Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 1991; 12:611-620.[Abstract]
  20. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998; 18:583-609.[Medline]
  21. Ramadan NM, Deveshwar R, Levine SR. Magnetic resonance and clinical cerebrovascular disease: an update. Stroke 1989; 20:1279-1283.[Abstract/Free Full Text]
  22. Nightingale SL. T-PA approved for acute ischemic stroke (from the Food and Drug Administration). JAMA 1996; 276:443.[Medline]
  23. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke—summary statement. Neurology 1996; 47:835-839.[Free Full Text]
  24. Special Writing Committee of the Stroke Council. American Heart Association. Guidelines for thrombolytic therapy for acute stroke: summary statement. Neurology 1996; 27:1711-1718.
  25. Fleming KA. Evidence-based pathology. Evidence Based Med 1997; 2:132-133.



This article has been cited by other articles:


Home page
RadiologyHome page
W. A. Willinek, J. Gieseke, M. von Falkenhausen, B. Neuen, H. H. Schild, and C. K. Kuhl
Sensitivity Encoding for Fast MR Imaging of the Brain in Patients with Stroke
Radiology, September 1, 2003; 228(3): 669 - 675.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, A. J.
Right arrow Articles by Littenberg, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. J.
Right arrow Articles by Littenberg, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE